nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.164	0.254	CbGbCtD
Zoledronate—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.142	0.219	CbGbCtD
Zoledronate—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.124	0.192	CbGbCtD
Zoledronate—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.124	0.192	CbGbCtD
Zoledronate—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0921	0.143	CbGbCtD
Zoledronate—GGPS1—retina—acquired immunodeficiency syndrome	0.00477	0.0622	CbGeAlD
Zoledronate—FDPS—blood plasma—acquired immunodeficiency syndrome	0.00401	0.0524	CbGeAlD
Zoledronate—GGPS1—lymphoid tissue—acquired immunodeficiency syndrome	0.00339	0.0443	CbGeAlD
Zoledronate—GGPS1—blood—acquired immunodeficiency syndrome	0.00319	0.0416	CbGeAlD
Zoledronate—GGPS1—bone marrow—acquired immunodeficiency syndrome	0.00308	0.0403	CbGeAlD
Zoledronate—GGPS1—spinal cord—acquired immunodeficiency syndrome	0.00307	0.0401	CbGeAlD
Zoledronate—GGPS1—vagina—acquired immunodeficiency syndrome	0.00296	0.0386	CbGeAlD
Zoledronate—GGPS1—lung—acquired immunodeficiency syndrome	0.00279	0.0365	CbGeAlD
Zoledronate—GGPS1—nervous system—acquired immunodeficiency syndrome	0.00259	0.0338	CbGeAlD
Zoledronate—GGPS1—central nervous system—acquired immunodeficiency syndrome	0.00249	0.0325	CbGeAlD
Zoledronate—CA2—blood plasma—acquired immunodeficiency syndrome	0.00208	0.0272	CbGeAlD
Zoledronate—GGPS1—brain—acquired immunodeficiency syndrome	0.00198	0.0258	CbGeAlD
Zoledronate—FDPS—skin of body—acquired immunodeficiency syndrome	0.00193	0.0252	CbGeAlD
Zoledronate—GGPS1—lymph node—acquired immunodeficiency syndrome	0.00191	0.025	CbGeAlD
Zoledronate—CA14—spinal cord—acquired immunodeficiency syndrome	0.00184	0.024	CbGeAlD
Zoledronate—FDPS—lymphoid tissue—acquired immunodeficiency syndrome	0.00156	0.0204	CbGeAlD
Zoledronate—CA12—digestive system—acquired immunodeficiency syndrome	0.00156	0.0204	CbGeAlD
Zoledronate—FDPS—digestive system—acquired immunodeficiency syndrome	0.00154	0.0202	CbGeAlD
Zoledronate—FDPS—blood—acquired immunodeficiency syndrome	0.00147	0.0192	CbGeAlD
Zoledronate—FDPS—bone marrow—acquired immunodeficiency syndrome	0.00142	0.0186	CbGeAlD
Zoledronate—FDPS—spinal cord—acquired immunodeficiency syndrome	0.00142	0.0185	CbGeAlD
Zoledronate—FDPS—vagina—acquired immunodeficiency syndrome	0.00136	0.0178	CbGeAlD
Zoledronate—CA12—lung—acquired immunodeficiency syndrome	0.0013	0.017	CbGeAlD
Zoledronate—FDPS—lung—acquired immunodeficiency syndrome	0.00129	0.0168	CbGeAlD
Zoledronate—CA12—nervous system—acquired immunodeficiency syndrome	0.00121	0.0158	CbGeAlD
Zoledronate—FDPS—nervous system—acquired immunodeficiency syndrome	0.00119	0.0156	CbGeAlD
Zoledronate—CA14—brain—acquired immunodeficiency syndrome	0.00118	0.0154	CbGeAlD
Zoledronate—CA12—central nervous system—acquired immunodeficiency syndrome	0.00116	0.0152	CbGeAlD
Zoledronate—FDPS—central nervous system—acquired immunodeficiency syndrome	0.00115	0.015	CbGeAlD
Zoledronate—CA2—retina—acquired immunodeficiency syndrome	0.00114	0.0149	CbGeAlD
Zoledronate—CA2—skin of body—acquired immunodeficiency syndrome	0.001	0.0131	CbGeAlD
Zoledronate—CA12—brain—acquired immunodeficiency syndrome	0.000922	0.012	CbGeAlD
Zoledronate—FDPS—brain—acquired immunodeficiency syndrome	0.000912	0.0119	CbGeAlD
Zoledronate—FDPS—lymph node—acquired immunodeficiency syndrome	0.000881	0.0115	CbGeAlD
Zoledronate—ABCC1—blood—acquired immunodeficiency syndrome	0.000854	0.0111	CbGeAlD
Zoledronate—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000811	0.0106	CbGeAlD
Zoledronate—CA2—digestive system—acquired immunodeficiency syndrome	0.000801	0.0105	CbGeAlD
Zoledronate—ABCC1—vagina—acquired immunodeficiency syndrome	0.000791	0.0103	CbGeAlD
Zoledronate—CA2—blood—acquired immunodeficiency syndrome	0.000763	0.00997	CbGeAlD
Zoledronate—ABCC1—lung—acquired immunodeficiency syndrome	0.000748	0.00977	CbGeAlD
Zoledronate—CA2—bone marrow—acquired immunodeficiency syndrome	0.000738	0.00964	CbGeAlD
Zoledronate—CA2—spinal cord—acquired immunodeficiency syndrome	0.000735	0.0096	CbGeAlD
Zoledronate—CA2—vagina—acquired immunodeficiency syndrome	0.000707	0.00924	CbGeAlD
Zoledronate—CA2—lung—acquired immunodeficiency syndrome	0.000669	0.00874	CbGeAlD
Zoledronate—CA2—nervous system—acquired immunodeficiency syndrome	0.000619	0.00809	CbGeAlD
Zoledronate—CA2—central nervous system—acquired immunodeficiency syndrome	0.000596	0.00779	CbGeAlD
Zoledronate—ABCC1—brain—acquired immunodeficiency syndrome	0.00053	0.00692	CbGeAlD
Zoledronate—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000512	0.00668	CbGeAlD
Zoledronate—CA2—brain—acquired immunodeficiency syndrome	0.000473	0.00618	CbGeAlD
Zoledronate—CA2—lymph node—acquired immunodeficiency syndrome	0.000457	0.00598	CbGeAlD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000586	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000584	CcSEcCtD
Zoledronate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000162	0.000583	CcSEcCtD
Zoledronate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000583	CcSEcCtD
Zoledronate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000583	CcSEcCtD
Zoledronate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000583	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000582	CcSEcCtD
Zoledronate—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000582	CcSEcCtD
Zoledronate—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000581	CcSEcCtD
Zoledronate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000578	CcSEcCtD
Zoledronate—Pain—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000578	CcSEcCtD
Zoledronate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000578	CcSEcCtD
Zoledronate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000578	CcSEcCtD
Zoledronate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000578	CcSEcCtD
Zoledronate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000577	CcSEcCtD
Zoledronate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000576	CcSEcCtD
Zoledronate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.000575	CcSEcCtD
Zoledronate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.000575	CcSEcCtD
Zoledronate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.000574	CcSEcCtD
Zoledronate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000574	CcSEcCtD
Zoledronate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000573	CcSEcCtD
Zoledronate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000159	0.000572	CcSEcCtD
Zoledronate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000159	0.000572	CcSEcCtD
Zoledronate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000571	CcSEcCtD
Zoledronate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000571	CcSEcCtD
Zoledronate—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00057	CcSEcCtD
Zoledronate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00057	CcSEcCtD
Zoledronate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.00057	CcSEcCtD
Zoledronate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000569	CcSEcCtD
Zoledronate—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000568	CcSEcCtD
Zoledronate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000568	CcSEcCtD
Zoledronate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000568	CcSEcCtD
Zoledronate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000568	CcSEcCtD
Zoledronate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000566	CcSEcCtD
Zoledronate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000565	CcSEcCtD
Zoledronate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000156	0.000564	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000564	CcSEcCtD
Zoledronate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000562	CcSEcCtD
Zoledronate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000561	CcSEcCtD
Zoledronate—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000559	CcSEcCtD
Zoledronate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000557	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000557	CcSEcCtD
Zoledronate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000556	CcSEcCtD
Zoledronate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000555	CcSEcCtD
Zoledronate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000555	CcSEcCtD
Zoledronate—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000555	CcSEcCtD
Zoledronate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.000555	CcSEcCtD
Zoledronate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000554	CcSEcCtD
Zoledronate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000553	CcSEcCtD
Zoledronate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000153	0.000553	CcSEcCtD
Zoledronate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000553	CcSEcCtD
Zoledronate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000553	CcSEcCtD
Zoledronate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000552	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000552	CcSEcCtD
Zoledronate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000551	CcSEcCtD
Zoledronate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.000551	CcSEcCtD
Zoledronate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000551	CcSEcCtD
Zoledronate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000549	CcSEcCtD
Zoledronate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000549	CcSEcCtD
Zoledronate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000549	CcSEcCtD
Zoledronate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000546	CcSEcCtD
Zoledronate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000546	CcSEcCtD
Zoledronate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000546	CcSEcCtD
Zoledronate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000152	0.000546	CcSEcCtD
Zoledronate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000546	CcSEcCtD
Zoledronate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000545	CcSEcCtD
Zoledronate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000151	0.000545	CcSEcCtD
Zoledronate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000544	CcSEcCtD
Zoledronate—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000543	CcSEcCtD
Zoledronate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000543	CcSEcCtD
Zoledronate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000541	CcSEcCtD
Zoledronate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000541	CcSEcCtD
Zoledronate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000541	CcSEcCtD
Zoledronate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00054	CcSEcCtD
Zoledronate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00054	CcSEcCtD
Zoledronate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000539	CcSEcCtD
Zoledronate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000538	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000538	CcSEcCtD
Zoledronate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000537	CcSEcCtD
Zoledronate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000535	CcSEcCtD
Zoledronate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000535	CcSEcCtD
Zoledronate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000534	CcSEcCtD
Zoledronate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000534	CcSEcCtD
Zoledronate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000534	CcSEcCtD
Zoledronate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000533	CcSEcCtD
Zoledronate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000533	CcSEcCtD
Zoledronate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000148	0.000532	CcSEcCtD
Zoledronate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000531	CcSEcCtD
Zoledronate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000529	CcSEcCtD
Zoledronate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.000529	CcSEcCtD
Zoledronate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.000529	CcSEcCtD
Zoledronate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000528	CcSEcCtD
Zoledronate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000528	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000528	CcSEcCtD
Zoledronate—Rash—Stavudine—acquired immunodeficiency syndrome	0.000146	0.000527	CcSEcCtD
Zoledronate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000527	CcSEcCtD
Zoledronate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000146	0.000527	CcSEcCtD
Zoledronate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000526	CcSEcCtD
Zoledronate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000526	CcSEcCtD
Zoledronate—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000526	CcSEcCtD
Zoledronate—Headache—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000524	CcSEcCtD
Zoledronate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000145	0.000524	CcSEcCtD
Zoledronate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000523	CcSEcCtD
Zoledronate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000523	CcSEcCtD
Zoledronate—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000523	CcSEcCtD
Zoledronate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000522	CcSEcCtD
Zoledronate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000522	CcSEcCtD
Zoledronate—Rash—Abacavir—acquired immunodeficiency syndrome	0.000144	0.00052	CcSEcCtD
Zoledronate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000144	0.000519	CcSEcCtD
Zoledronate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000519	CcSEcCtD
Zoledronate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000519	CcSEcCtD
Zoledronate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000519	CcSEcCtD
Zoledronate—Headache—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000516	CcSEcCtD
Zoledronate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000516	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000515	CcSEcCtD
Zoledronate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000515	CcSEcCtD
Zoledronate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000514	CcSEcCtD
Zoledronate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000511	CcSEcCtD
Zoledronate—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000511	CcSEcCtD
Zoledronate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000509	CcSEcCtD
Zoledronate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000508	CcSEcCtD
Zoledronate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000508	CcSEcCtD
Zoledronate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000508	CcSEcCtD
Zoledronate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000507	CcSEcCtD
Zoledronate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000505	CcSEcCtD
Zoledronate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000505	CcSEcCtD
Zoledronate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000504	CcSEcCtD
Zoledronate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000504	CcSEcCtD
Zoledronate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000504	CcSEcCtD
Zoledronate—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000502	CcSEcCtD
Zoledronate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000502	CcSEcCtD
Zoledronate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.0005	CcSEcCtD
Zoledronate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000498	CcSEcCtD
Zoledronate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000498	CcSEcCtD
Zoledronate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000498	CcSEcCtD
Zoledronate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000497	CcSEcCtD
Zoledronate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000497	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000496	CcSEcCtD
Zoledronate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000495	CcSEcCtD
Zoledronate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000492	CcSEcCtD
Zoledronate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000491	CcSEcCtD
Zoledronate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000489	CcSEcCtD
Zoledronate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000489	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000488	CcSEcCtD
Zoledronate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000487	CcSEcCtD
Zoledronate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000486	CcSEcCtD
Zoledronate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000485	CcSEcCtD
Zoledronate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000485	CcSEcCtD
Zoledronate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000485	CcSEcCtD
Zoledronate—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000484	CcSEcCtD
Zoledronate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000483	CcSEcCtD
Zoledronate—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000483	CcSEcCtD
Zoledronate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000483	CcSEcCtD
Zoledronate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000483	CcSEcCtD
Zoledronate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000481	CcSEcCtD
Zoledronate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000479	CcSEcCtD
Zoledronate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000478	CcSEcCtD
Zoledronate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000473	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000473	CcSEcCtD
Zoledronate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000471	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00047	CcSEcCtD
Zoledronate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000469	CcSEcCtD
Zoledronate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000469	CcSEcCtD
Zoledronate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000466	CcSEcCtD
Zoledronate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000466	CcSEcCtD
Zoledronate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000465	CcSEcCtD
Zoledronate—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000465	CcSEcCtD
Zoledronate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000463	CcSEcCtD
Zoledronate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000463	CcSEcCtD
Zoledronate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000462	CcSEcCtD
Zoledronate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000462	CcSEcCtD
Zoledronate—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000461	CcSEcCtD
Zoledronate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000458	CcSEcCtD
Zoledronate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000458	CcSEcCtD
Zoledronate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000458	CcSEcCtD
Zoledronate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000457	CcSEcCtD
Zoledronate—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000455	CcSEcCtD
Zoledronate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000452	CcSEcCtD
Zoledronate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000451	CcSEcCtD
Zoledronate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.00045	CcSEcCtD
Zoledronate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000449	CcSEcCtD
Zoledronate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000448	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000448	CcSEcCtD
Zoledronate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000447	CcSEcCtD
Zoledronate—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000447	CcSEcCtD
Zoledronate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000447	CcSEcCtD
Zoledronate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000447	CcSEcCtD
Zoledronate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000445	CcSEcCtD
Zoledronate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000444	CcSEcCtD
Zoledronate—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000444	CcSEcCtD
Zoledronate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000439	CcSEcCtD
Zoledronate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000437	CcSEcCtD
Zoledronate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000432	CcSEcCtD
Zoledronate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000432	CcSEcCtD
Zoledronate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000432	CcSEcCtD
Zoledronate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00043	CcSEcCtD
Zoledronate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00043	CcSEcCtD
Zoledronate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000119	0.00043	CcSEcCtD
Zoledronate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000428	CcSEcCtD
Zoledronate—Rash—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000426	CcSEcCtD
Zoledronate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000426	CcSEcCtD
Zoledronate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000424	CcSEcCtD
Zoledronate—Headache—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000424	CcSEcCtD
Zoledronate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000422	CcSEcCtD
Zoledronate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000418	CcSEcCtD
Zoledronate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000416	CcSEcCtD
Zoledronate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000412	CcSEcCtD
Zoledronate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00041	CcSEcCtD
Zoledronate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00041	CcSEcCtD
Zoledronate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000406	CcSEcCtD
Zoledronate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000406	CcSEcCtD
Zoledronate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000404	CcSEcCtD
Zoledronate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000403	CcSEcCtD
Zoledronate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000402	CcSEcCtD
Zoledronate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000402	CcSEcCtD
Zoledronate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000401	CcSEcCtD
Zoledronate—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.0004	CcSEcCtD
Zoledronate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.0004	CcSEcCtD
Zoledronate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00039	CcSEcCtD
Zoledronate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000389	CcSEcCtD
Zoledronate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000387	CcSEcCtD
Zoledronate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000385	CcSEcCtD
Zoledronate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000385	CcSEcCtD
Zoledronate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000385	CcSEcCtD
Zoledronate—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000383	CcSEcCtD
Zoledronate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000382	CcSEcCtD
Zoledronate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000379	CcSEcCtD
Zoledronate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000374	CcSEcCtD
Zoledronate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000372	CcSEcCtD
Zoledronate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000372	CcSEcCtD
Zoledronate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000367	CcSEcCtD
Zoledronate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000363	CcSEcCtD
Zoledronate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.98e-05	0.00036	CcSEcCtD
Zoledronate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.97e-05	0.000359	CcSEcCtD
Zoledronate—Rash—Ritonavir—acquired immunodeficiency syndrome	9.89e-05	0.000356	CcSEcCtD
Zoledronate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.88e-05	0.000356	CcSEcCtD
Zoledronate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.85e-05	0.000355	CcSEcCtD
Zoledronate—Headache—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.000354	CcSEcCtD
Zoledronate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.6e-05	0.000346	CcSEcCtD
Zoledronate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.000343	CcSEcCtD
Zoledronate—Rash—Saquinavir—acquired immunodeficiency syndrome	9.52e-05	0.000343	CcSEcCtD
Zoledronate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.51e-05	0.000343	CcSEcCtD
Zoledronate—Headache—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000341	CcSEcCtD
Zoledronate—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000336	CcSEcCtD
Zoledronate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.16e-05	0.00033	CcSEcCtD
Zoledronate—Rash—Lamivudine—acquired immunodeficiency syndrome	9.08e-05	0.000327	CcSEcCtD
Zoledronate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000327	CcSEcCtD
Zoledronate—Headache—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000325	CcSEcCtD
Zoledronate—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000323	CcSEcCtD
Zoledronate—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000308	CcSEcCtD
